Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 35, 2020 - Issue 1
Short Communication
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
, , , , , , , 
, & show all
Zhenchao Wangb School of Pharmaceutical Sciences, Guizhou University, Guiyang, China;c Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-1859-0128View further author information
https://orcid.org/0000-0003-1859-0128View further author information, & show allRelated Research Data
A small molecule-kinase interaction map for clinical kinase inhibitors.
Source:
Springer Science and Business Media LLC
Novel 4-arylaminoquinazolines bearing N,N-diethyl(aminoethyl)amino moiety with antitumour activity as EGFRwt-TK inhibitor.
Source:
Taylor & Francis Group
Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors.
Source:
Elsevier BV
Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.
Source:
Portland Press Ltd.
Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.
Source:
Ovid Technologies (Wolters Kluwer Health)
Design and synthesis of quinazolinones as EGFR inhibitors to overcome EGFR resistance obstacle
Source:
Elsevier BV
Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization
Source:
MDPI AG
Cyclization of 2-Benzoylamino-N-methyl-thiobenzamides to 3-Methyl-2-phenylquinazolin-4-thiones.
Source:
Wiley
Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy.
Source:
Elsevier BV
Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2.
Source:
Elsevier BV
Linking provided by
